|
|
 |
 |
|
|
|
|
MammoSite 5-day Targeted Radiation Therapy is a treatment option for early-stage breast cancer in select patients. This section of the Web site presents topics of potential interest to physicians who use, or are considering the use of, MammoSite 5-day TRT.
Topics covered in this section include:
- Accelerated Partial Breast Irradiation (APBI): This technique is an alternative to exposing the entire breast to potentially harmful radiation.
- Patient Selection: Important criteria for increasing the likelihood of successful outcomes.
- Surgical Procedure: MammoSite Radiation Therapy System (RTS), device implantation methods using a small incision.
- Clinical Data: Initial and current clinical trial results, including 5-year data.
- Treatment Planning: Treatment considerations when scheduling MammoSite therapy.
- Cosmesis, Seroma, Infection: Viewpoints, incidence and strategies for three important areas of focus regarding treatment with Accelerated Partial Breast Irradiation. (APBI).
- Patient Education: Suggestions for discussing with your patients MammoSite therapy as a treatment option.
|
|
|
|
|
|
